-       Report 
- January 2025
-  150 Pages 
- Global 
   From       €5295EUR$5,950USD£4,661GBP 
            -       Report 
- October 2025
-  193 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
          -       Report 
- October 2025
-  381 Pages 
- Global 
   From       €5206EUR$5,850USD£4,582GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
          -       Report 
- May 2025
-  180 Pages 
- Global 
   From       €4004EUR$4,500USD£3,525GBP 
             -       Report 
- February 2025
-  130 Pages 
- Global 
   From       €3668EUR$4,123USD£3,229GBP 
      €4316EUR$4,850USD£3,799GBP 
          -       Report 
- April 2023
-  120 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- November 2023
-  115 Pages 
- Global 
   From       €3500EUR$4,213USD£3,189GBP 
          -       Report 
- April 2024
-  132 Pages 
- Global 
   From       €845EUR$950USD£744GBP 
             Peptide antibiotics are a type of antibiotic derived from peptides, which are short chains of amino acids. They are used to treat a variety of bacterial infections, including those caused by Gram-positive and Gram-negative bacteria. Peptide antibiotics are generally more effective than traditional antibiotics, as they are able to target specific bacterial cells and are less likely to cause resistance. They are also less likely to cause side effects, such as nausea and vomiting. Peptide antibiotics    are typically administered intravenously or intramuscularly, and can be used in combination with other antibiotics.
The peptide antibiotics market is growing rapidly, driven by the increasing prevalence of antibiotic-resistant bacteria and the need for more effective treatments. The market is expected to continue to grow in the coming years, as more research is conducted into the development of new peptide antibiotics.
Some companies in the peptide antibiotics market include Merck, Pfizer, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less   Read more